Autopsy report · NCT05312021

Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study Termination”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Cardurion Pharmaceuticals, Inc.
Sponsor type: Industry
Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: IMR-687; IMR-687 Placebo
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.